Recently, Synbio Technologies signed a research and development cooperation agreement with South Korea’s Cosmax Group. The two companies will jointly conduct in-depth research on the effects of Lactiplantibacillus plantarum TWK10® on metabolic syndrome. Source: Synbio Technologies Probiotics.
Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE
Visit HPA-China’s Information Hub, HERE